These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35108248)

  • 1. Tyrame [N-(3-hydroxy-1:3:5(10)-estratrien-17β-yl)-4-hydroxy-phenethylamine], antithrombotic aminoestrogen that decreases microvesicle formation.
    Flores-García M; Fernández-González JM; León-Martínez M; Hernández-Ortega S; Hernández-López JR; Reyes-Munguía D; Sánchez-Sarabia H; Piña-Fragoso Z; Peña-Díaz A
    Gac Med Mex; 2021; 157(6):588-593. PubMed ID: 35108248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structures and inhibitory effects of Buame [N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-butylamine] and Diebud [N,N'-bis-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-1,4-butanediamine] on platelet aggregation.
    Flores-García M; Fernández-G JM; León-Martínez M; Hernández-Ortega S; Pérez-Méndez O; Correa-Basurto J; Carreón-Torres E; Tolentino-López LE; Ceballos-Reyes GM; de la Peña-Díaz A
    Steroids; 2012 Apr; 77(5):512-20. PubMed ID: 22326683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet, anticoagulant and fibrinolytic effects of Litchi chinensis Sonn. extract.
    Sung YY; Yang WK; Kim HK
    Mol Med Rep; 2012 Mar; 5(3):721-4. PubMed ID: 22200762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antithrombotic effect of the aminoestrogen prolame (N-(3-hydroxy-1,3,5(10)-estratrien-17B-YL)-3-hydroxypropylamine) is linked to an increase in nitric oxide production by platelets and endothelial cells.
    González G; Alvarado-Vasquez N; Fernández-G JM; Cruz-Robles D; Del Valle L; Pinzón E; Torres I; Rodriguez E; Zapata E; Gómez-Vidales V; Montaño LF; de la Peña A
    Atherosclerosis; 2010 Jan; 208(1):62-8. PubMed ID: 19615684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Antithrombotic Activity and Diminished Bleeding Side Effect of a PEGylated α
    Kuo YJ; Chang YT; Chung CH; Chuang WJ; Huang TF
    Toxins (Basel); 2020 Jun; 12(7):. PubMed ID: 32605221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities.
    Kuo HL; Lien JC; Chung CH; Chang CH; Lo SC; Tsai IC; Peng HC; Kuo SC; Huang TF
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):495-505. PubMed ID: 20349046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
    Song Q; Wang S; Zhao W
    J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and antithrombotic activities of Korean Red Ginseng.
    Yu JY; Jin YR; Lee JJ; Chung JH; Noh JY; You SH; Kim KN; Im JH; Lee JH; Seo JM; Han HJ; Lim Y; Park ES; Kim TJ; Shin KS; Wee JJ; Park JD; Yun YP
    Arch Pharm Res; 2006 Oct; 29(10):898-903. PubMed ID: 17121186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist.
    Dumas M; Nadal-Wollbold F; Gaussem P; Perez M; Mirault T; Létienne R; Bourbon T; Grelac F; Le Grand B; Bachelot-Loza C
    Br J Pharmacol; 2012 Mar; 165(6):1827-1835. PubMed ID: 21913899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glybenclamide: an antidiabetic with in vivo antithrombotic activity.
    Ting HJ; Khasawneh FT
    Eur J Pharmacol; 2010 Dec; 649(1-3):249-54. PubMed ID: 20858477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of J78, a newly synthesized 1,4-naphthoquinone derivative, on experimental thrombosis and platelet aggregation.
    Jin YR; Ryu CK; Moon CK; Cho MR; Yun YP
    Pharmacology; 2004 Apr; 70(4):195-200. PubMed ID: 15001820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cilostazol on platelet aggregation and experimental thrombosis.
    Kimura Y; Tani T; Kanbe T; Watanabe K
    Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
    Petzold T; Thienel M; Dannenberg L; Mourikis P; Helten C; Ayhan A; M'Pembele R; Achilles A; Trojovky K; Konsek D; Zhang Z; Regenauer R; Pircher J; Ehrlich A; Lüsebrink E; Nicolai L; Stocker TJ; Brandl R; Röschenthaler F; Strecker J; Saleh I; Spannagl M; Mayr CH; Schiller HB; Jung C; Gerdes N; Hoffmann T; Levkau B; Hohlfeld T; Zeus T; Schulz C; Kelm M; Polzin A
    Circ Res; 2020 Feb; 126(4):486-500. PubMed ID: 31859592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anticoagulant effect of hexolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect.
    Rubio-Póo C; Lemini C; García-Mondragón J; de la Peña A; Jayme V; Mendoza-Patiño N; Zavala E; Silva G; Blickenstaff RT; Fernández JM
    Steroids; 1990 Feb; 55(2):83-6. PubMed ID: 2326832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Jeon YD; Lee JH; Park MR; Lim JY; Kang SH; Kim DK; Lee YM
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684165
    [No Abstract]   [Full Text] [Related]  

  • 18. The antithrombotic effect of borneol related to its anticoagulant property.
    Li YH; Sun XP; Zhang YQ; Wang NS
    Am J Chin Med; 2008; 36(4):719-27. PubMed ID: 18711769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-thrombotic efficacy of S007-867: Pre-clinical evaluation in experimental models of thrombosis in vivo and in vitro.
    Misra A; Prakash P; Aggarwal H; Dhankani P; Kumar S; Pandey CP; Pugh N; Bihan D; Barthwal MK; Farndale RW; Dikshit DK; Dikshit M
    Biochem Pharmacol; 2018 Feb; 148():288-297. PubMed ID: 29309758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.